Both parameters, K-FLC in CSF and kappa index (K-Index = CSF/serum K-FLC divided by CSF/serum albumin), have shown to be increased in patients with CIS and MS as compared with control groups (15–17). This evidence concerns the gene ALB and myeloid sarcoma.